↓ Skip to main content

HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
Published in
Journal for Immunotherapy of Cancer, March 2019
DOI 10.1186/s40425-019-0554-8
Pubmed ID
Authors

Chu-Yu Jing, Yi-Peng Fu, Yong Yi, Mei-Xia Zhang, Su-Su Zheng, Jin-Long Huang, Wei Gan, Xin Xu, Jia-Jia Lin, Juan Zhang, Shuang-Jian Qiu, Bo-Heng Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Professor 7 14%
Student > Master 6 12%
Student > Ph. D. Student 5 10%
Student > Bachelor 5 10%
Student > Doctoral Student 5 10%
Other 9 18%
Unknown 13 26%
Readers by discipline Count As %
Medicine and Dentistry 19 38%
Biochemistry, Genetics and Molecular Biology 7 14%
Immunology and Microbiology 3 6%
Agricultural and Biological Sciences 3 6%
Chemical Engineering 1 2%
Other 3 6%
Unknown 14 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2019.
All research outputs
#16,292,673
of 25,728,855 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,739
of 3,495 outputs
Outputs of similar age
#219,673
of 380,205 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#82
of 87 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,495 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,205 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.